(Q44118699)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

liver transplantation

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Enrico Regalia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Nicola Zucchini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ferruccio Bonino

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Tagger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Schiavo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Pulvirenti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M L Ribero

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Coppa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

R Romito

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

L Burgoa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Urbanek

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1355-1357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

Liver transplantation for chronic viral hepatitis

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2800%2902508-2

7 January 2021

10.1016/S0041-1345(00)02508-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11267325%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference